| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.084 | 0.08 |